Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers

NCT02259972 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 113823 solution
DRUG: BI 113823 tablet
DRUG: Placebo
OTHER: High fat, high calorie breakfast

Sponsor

Boehringer Ingelheim